생물 안전 캐비닛 시장 : 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the biological safety cabinets market size was valued at USD 262.21 million in 2025 and estimated to grow from USD 282.55 million in 2026 to reach USD 410.39 million by 2031, at a CAGR of 7.76% during the forecast period (2026-2031).

This report is Segmented by Type (Class I, Class II, and Class III), Exhaust System (Ducted (Hard-Connected) and Recirculating / Ductless), Application (Drug Discovery & Pre-Clinical R&D, and More), End-User (Academic & Research Institutes, and More), Geography (North America, Europe, Asia-Pacific, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Biological Safety Cabinet Market Trends and Insights

Expanding Pharmaceutical and Biotechnology Research Expenditure

Robust drug-development pipelines are prompting large companies to build redundant research hubs that need new containment suites. Thermo Fisher Scientific is allocating USD 1.5 billion of its four-year U.S. investment program to laboratory infrastructure that includes biological safety cabinets. Mergers that add late-stage assets further boost facility retrofits, and AI-enabled discovery platforms are re-configuring workspaces for automated, high-throughput assays that still require operator protection. As a result, the biological safety cabinets market gains additional pull-through from every newly equipped research laboratory. Universities benefit from expanded grant funding that covers biosafety upgrades, supporting steady public-sector demand. The trend is most visible in North America, but similar capacity builds are underway in Western Europe.

Escalating Global Preparedness for Emerging Infectious Diseases

Governments have prioritized resilient laboratory networks since 2024. The CDC's sixth edition of the Biosafety in Microbiological and Biomedical Laboratories outlines tighter performance criteria for airflow and filter integrity, prompting cabinet replacement cycles. OSHA's forthcoming infectious-disease rule will extend similar requirements to clinical laboratories, accelerating domestic orders. Defense programs that study bioaerosol threats also rely on HEPA-filtered workstations, underlining cross-sector demand. National stockpiles of rapid-response testing infrastructure now routinely include biosafety cabinets, ensuring immediate deployment during outbreaks. This focus on readiness sustains short-term growth, particularly in Asia-Pacific where public-health laboratories are scaling up.

High Capital and Certification Costs

Total installed cost often doubles list price once validation, construction modifications, and GMP documentation are added. Academic laboratories struggle to fund upgrades because research grants rarely cover infrastructure. Uncertainty over future certification rules tied to ISO 14644-4 has prompted some buyers to postpone orders. Smaller biotech firms mitigate expense by leasing shared lab space, which delays direct equipment sales. Custom validation for potent-compound handling pushes expenses higher, particularly for first-time CDMOs.

Other drivers and restraints analyzed in the detailed report include:

1. Stringent Occupational Health and Safety Regulations
2. Accelerating Cell and Gene Therapy Manufacturing Expansion
3. Emergence of Alternative Closed Isolator Systems

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Class II units retained 60.88% of the biological safety cabinets market share in 2025 because they meet the majority of routine research and diagnostic needs. However, Class III glove-box designs are on a 10.01% CAGR trajectory thanks to rising HPAPI and viral-vector handling requirements. Esco's leak-tight Class III series supports chemotherapy compounding and vaccine formulation while ensuring zero operator exposure. The biological safety cabinets market size for Class III units is projected to grow rapidly as CRISPR and oncolytic-virus pipelines expand. Across all classes, manufacturers embed touch-screen airflow analytics and automatic pressure-decay tests that simplify annual recertification. Energy-optimization remains a cross-class design focus to satisfy ISO-driven lifecycle cost mandates.

Technological parity is narrowing, yet Class I equipment remains niche, serving teaching labs that require personnel and environmental protection without the product shielding offered by higher classes. Software integrations now push usage data to building-management systems, enabling laboratory managers to demonstrate ventilation compliance in real time. Global harmonization of airflow velocity targets is expected to drive retrofits, sustaining demand for all classes within the biological safety cabinets market.

Ducted configurations captured 57.92% of revenue in 2025 due to regulatory preference in GMP suites. They remain indispensable where direct hazardous-air removal is mandated, especially in large biopharmaceutical campuses. Even so, ductless units are advancing at a 10.28% CAGR because they avoid costly HVAC rework in space-constrained buildings. The biological safety cabinets market size for ductless models will accelerate in emerging economies where laboratory retrofits exceed new-build projects. Better Basics Laborbedarf's SmartIntegrate module boosts workstation efficiency by 30% and allows tool-free filter swaps, illustrating innovation in this segment.

Energy codes pushing toward net-zero buildings give ductless units an advantage by minimizing conditioned-air losses. Suppliers now offer hybrid models that allow future conversion between ducted and recirculating modes, protecting customer capital as regulations evolve. Despite these gains, high-risk HPAPI suites still specify hard-ducted exhaust to guarantee negative pressure, so both systems will coexist in the biological safety cabinets market.

Complete Report Scope:

• By Type
  • Class I
  • Class II
  • Class III
• By Exhaust System
  • Ducted (Hard-Connected)
  • Recirculating / Ductless
• By Application
  • Drug Discovery & Pre-Clinical R&D
  • Clinical / Diagnostic Testing Labs
  • Biopharmaceutical Manufacturing & Fill-Finish
• By End-User
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research / CDMOs
  • Other End Users
• Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America led the biological safety cabinets market at 41.98% revenue share in 2025. Large-scale projects such as Novo Nordisk's 1.4-million-square-foot aseptic facility and Thermo Fisher Scientific's multiyear capital program underscore sustained equipment pull. FDA adoption of ISO 14644-4 plus OSHA's forthcoming infectious-disease rule create back-to-back compliance cycles that compel cabinet upgrades. Federal incentives for reshoring pharmaceutical supply chains also channel investment into U.S. CDMO campuses that specify high-containment designs.

Asia-Pacific is the fastest-growing region at a 9.22% CAGR through 2031. The US Biosecure Act is redirecting outsourcing toward India, where the CDMO market will climb from USD 15.63 billion in 2023 to USD 26.73 billion by 2028. Singapore's USD 150 million Pall Corporation filtration plant demonstrates the region's evolving ecosystem that integrates upstream consumables with cabinet manufacturing. China's ongoing pharmaceutical build-out and Japan's vaccine self-sufficiency plans further elevate demand. Harmonized standards simplify imports, encouraging multinational suppliers to locate final assembly closer to customers.

Europe shows steady expansion anchored by strict regulatory mandates and green-building directives. The Machinery Regulation and Ecodesign rules push laboratories to adopt energy-efficient units with digital passports. Rentschler Biopharma's buffer-media complex and other biologics investments bolster replacement demand for high-performance cabinets. The region's active-pharmaceutical-ingredient market growth supports modern GMP suites, lifting the biological safety cabinets market. Sustainability targets that require net-zero emissions by 2050 are tilting procurement toward ductless or low-pressure designs, reinforcing technology differentiation among suppliers.

1. Thermo Fisher Scientific
2. Esco Lifesciences
3. Labconco
4. The Baker Company
5. NuAire
6. Kewaunee Scientific
7. Germfree Laboratories
8. Air Science
9. BIOBASE
10. Telstar (Azbil)
11. Faster Srl
12. Haier Biomedical
13. PHCbi (Panasonic Healthcare)
14. Erlab
15. Bigneat
16. Shanghai Boxun
17. Heal Force
18. Angelantoni Life Science
19. AireLab Systems
20. Astec Microflow

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope Of The Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Expanding Pharmaceutical and Biotechnology Research Expenditure
  • 4.2.2 Escalating Global Preparedness for Emerging Infectious Diseases
  • 4.2.3 Stringent Occupational Health and Safety Regulations
  • 4.2.4 Accelerating Cell and Gene Therapy Manufacturing Expansion
  • 4.2.5 Rising Adoption of Smart Energy-Efficient Cabinet Technologies
• 4.3 Market Restraints
  • 4.3.1 High Capital and Certification Costs
  • 4.3.2 Emergence of Alternative Closed Isolator Systems
  • 4.3.3 Supply Chain Vulnerabilities In HEPA / ULPA Filtration Components
  • 4.3.4 Intensifying Energy Efficiency Compliance Pressure
• 4.4 Regulatory Landscape
• 4.5 Porter's Five Forces Analysis
  • 4.5.1 Threat Of New Entrants
  • 4.5.2 Bargaining Power Of Buyers
  • 4.5.3 Bargaining Power Of Suppliers
  • 4.5.4 Threat Of Substitutes
  • 4.5.5 Intensity Of Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Type
  • 5.1.1 Class I
  • 5.1.2 Class II
  • 5.1.3 Class III
• 5.2 By Exhaust System
  • 5.2.1 Ducted (Hard-Connected)
  • 5.2.2 Recirculating / Ductless
• 5.3 By Application
  • 5.3.1 Drug Discovery & Pre-Clinical R&D
  • 5.3.2 Clinical / Diagnostic Testing Labs
  • 5.3.3 Biopharmaceutical Manufacturing & Fill-Finish
• 5.4 By End-User
  • 5.4.1 Pharmaceutical & Biotechnology Companies
  • 5.4.2 Academic & Research Institutes
  • 5.4.3 Contract Research / CDMOs
  • 5.4.4 Other End Users
• 5.5 Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle East & Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East & Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and analysis of Recent Developments)
  • 6.3.1 Thermo Fisher Scientific, Inc.
  • 6.3.2 Esco Micro
  • 6.3.3 Labconco
  • 6.3.4 The Baker Company
  • 6.3.5 NuAire
  • 6.3.6 Kewaunee Scientific
  • 6.3.7 Germfree Laboratories
  • 6.3.8 Air Science
  • 6.3.9 BIOBASE
  • 6.3.10 Telstar (Azbil)
  • 6.3.11 Faster Srl
  • 6.3.12 Haier Biomedical
  • 6.3.13 PHCbi (Panasonic Healthcare)
  • 6.3.14 Erlab
  • 6.3.15 Bigneat
  • 6.3.16 Shanghai Boxun
  • 6.3.17 Heal Force
  • 6.3.18 Angelantoni Life Science
  • 6.3.19 AireLab Systems
  • 6.3.20 Astec Microflow

7 Market Opportunities & Future Outlook

• 7.1 White-Space & Unmet-Need Assessment